title: Comparison of 2,2-bis(bromomethyl)-1,3-propanediol induced genotoxicity in UROtsa cells and primary rat hepatocytes: relevance of metabolism and oxidative stress.
abstract: 2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant used in urethane foams and polyester resins. In a two year dietary study, BMP caused neoplastic lesions at multiple sites including the urinary bladder of both rats and mice. However, liver was not a target tissue. We previously reported that BMP elicited oxidative DNA damage in a human uroepithelial cell line (UROtsa). The present in vitro study investigated the susceptibility of target (UROtsa cells) and non-target cells (primary rat hepatocytes) to BMP-induced genotoxicity. In contrast to hepatocytes, BMP exhibited greater genotoxic potential in UROtsa cells as evidenced by the concentration dependent increase in DNA strand breaks and DNA binding. Total content of intracellular GSH quantified in UROtsa cells (2.7±1.0nmol/mg protein) was 4 fold lower than that in hepatocytes (10.7±0.3nmol/mg protein). HPLC analysis indicated BMP was not metabolized and/or consumed in UROtsa cells at any of the concentrations tested (10-250μM) but was extensively converted to a mono-glucuronide in hepatocytes. These results demonstrate that a target cell line such as UROtsa cells are more susceptible to BMP-induced DNA damage when compared to non-target cells. This increased susceptibility may relate to the deficiency of antioxidant and/or metabolic capabilities in UROtsa cells.
authors: Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, AZ 85724, United States. Electronic address: weixik@uci.edu.
authors: Weixi
authors: W
authors: Kong
authors: Pengfei
authors: P
authors: Gu
authors: Gabriel A
authors: GA
authors: Knudsen
authors: I Glenn
authors: IG
authors: Sipes
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D020552:Comet Assay; D004249:DNA Damage / Q000187:drug effects; D005978:Glutathione / Q000032:analysis; D022781:Hepatocytes / Q000737:chemistry / Q000187:drug effects*; D006801:Humans; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D011409:Propylene Glycols / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D019459:Urothelium / Q000166:cytology / Q000187:drug effects*
chemical_list: D002273:Carcinogens; D011409:Propylene Glycols; C060080:2,2-bis(bromomethyl)-1,3-propanediol; D005978:Glutathione
keywords: 2,2-Bis(bromomethyl)-1,3-propanediol; Cell susceptibility; Metabolism; Oxidative stress; Primary rat hepatocyte; UROtsa cell
references: J Clin Invest. 2000 May;105(9):1261-7
references: 10792001
references: Cancer Gene Ther. 2001 Oct;8(10):803-14
references: 11687904
references: J Pharmacol Exp Ther. 2001 Dec;299(3):998-1006
references: 11714888
references: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12871-6
references: 14566050
references: Biochem J. 1967 Jul;104(1):254-7
references: 4291998
references: Chemosphere. 2010 Apr;79(4):476-81
references: 20189218
references: Drug Metab Dispos. 2009 Feb;37(2):408-16
references: 19029203
references: Toxicology. 2011 Dec 18;290(2-3):271-7
references: 22019925
references: Biochim Biophys Acta. 1985 Dec 17;823(2):111-45
references: 3907708
references: Environ Health Perspect. 2001 Aug;109(8):801-8
references: 11564615
references: Natl Toxicol Program Tech Rep Ser. 1996 May;452:1-465
references: 12594523
references: Biochem Pharmacol. 2001 Mar 1;61(5):555-63
references: 11239498
references: Chem Res Toxicol. 2006 Dec;19(12):1580-94
references: 17173371
references: Proc Natl Acad Sci U S A. 2000 May 9;97(10):5381-6
references: 10792040
references: Toxicol Appl Pharmacol. 2011 Nov 15;257(1):1-13
references: 21925530
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: Drug Metab Dispos. 2010 Jun;38(6):957-62
references: 20200232
references: Radiat Res. 1990 Nov;124(2):242-5
references: 2247605
references: J Contam Hydrol. 2006 Aug 10;86(3-4):195-214
references: 16690162
references: Drug Metab Dispos. 2002 Nov;30(11):1180-5
references: 12386122